Prophylactic Use of Epidermal Growth Factor Reduces Ischemia/Reperfusion Intestinal Damage
- 1 August 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (2) , 373-379
- https://doi.org/10.1016/s0002-9440(10)64192-2
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (054787, 047231)
This publication has 41 references indexed in Scilit:
- Effects of inhibition of PDE4 and TNF‐α on local and remote injuries following ischaemia and reperfusion injuryBritish Journal of Pharmacology, 2001
- Epidermal growth factor enemas are effective in the treatment of left-sided ulcarative colitisGastroenterology, 2001
- Epidermal growth factor reduces multiorgan failure induced by thioacetamideGut, 2001
- Potency and stability of C terminal truncated human epidermal growth factorGut, 2000
- An Activated L-selectin Mutant with Conserved Equilibrium Binding Properties but Enhanced Ligand Recognition under Shear FlowPublished by Elsevier ,2000
- Experimental study of the effect of adrenaline tolerance on intestinal ischaemia–reperfusionBritish Journal of Surgery, 1998
- Differential Effects of EGF and Amphiregulin on Adhesion Molecule Expression and Migration of Colon Carcinoma CellsExperimental Cell Research, 1997
- Changes in rat liver gene expression induced by thioacetamide: Protective role of S -adenosyl-l-methionine by a glutathione-dependent mechanismHepatology, 1996
- Cell proliferation in the small intestine and colon of intravenously fed rats: effects of urogastrone-epidermal growth factorCell Proliferation, 1992
- Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coatBiochemical and Biophysical Research Communications, 1988